The Portuguese Institute of Oncology (IPO) of Coimbra invested EUR 4.5 million in equity in a single technology in the country for the treatment of cancer, particularly tumors treated by external radiation to the brain. the new tomoterapia unit allows, according to the president of the IPO of Coimbra, Manuel António Silva, a treatment “more efficiently and with better results for the patient,” and its creation “deserved the agreement” of the institution radiotherapy professionals, he said. According to a press note from the IPO, innovative technology enables the dose of radiation is directed to the target tumor, “saving expressively each of the organs at risk that may be in the immediate vicinity and the consistent, efficient and reliable administration of the same dose distribution. “ ” the duration of each treatment session shortens significantly, with increases not only efficiency, and convenience and well-being for the patient who fails to require long times to immobilization and postural rigidity “ reads the same information. “This new plant strengthens the capacity for radiotherapy in the NHS [National Health Service] or innovation that involves both the possibility of setting up as a reference whenever deemed treatment by ionizing radiation “it said. Manuel António Silva said, however, that the innovative technology” is available for everyone in Portugal, “not only for the patients in the IPO of Coimbra. “we already do in other areas, we are open to such collaboration. In the National Health Service communication between institutions is very positive, “he assured.
The new treatment plant is part of the ongoing investment plan in the IPO of Coimbra, an institution that is part of the platform” more differentiated “from the Hospital Referral Oncology Network,” which gave it the responsibility of the diagnosis and treatment of tumors, regardless of their impact, in particular those which require more complex techniques and technology and less vulgarized, “argues the press release .
No comments:
Post a Comment